Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

ImmunoGen Inc (IMGN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ImmunoGen's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
ImmunoGen historical data, for real-time data please try another search
31.230 0.000    0.00%
09/02 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 31.220 - 31.250
ImmunoGen 31.230 0.000 0.00%

IMGN Balance Sheet

 
Featured here, the Balance Sheet for ImmunoGen Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
30/09
 2023
30/06
 2023
31/03
 2022
31/12
Total Current Assets 766.9 669.27 243.86 304.12
Cash and Short Term Investments 605.54 571.99 201.25 275.14
Cash - - - -
Cash & Equivalents 605.54 571.99 201.25 275.14
Short Term Investments - - - -
Total Receivables, Net 137.16 79.96 31.05 17.98
Accounts Receivables - Trade, Net 137.16 79.96 31.05 17.98
Total Inventory 5.5 3.23 0.614 -
Prepaid Expenses 18.71 14.09 10.96 11
Other Current Assets, Total - - - -
Total Assets 822.1 714.33 288.34 348.94
Property/Plant/Equipment, Total - Net 12.77 12.77 13.69 14.61
Property/Plant/Equipment, Total - Gross - - - 45.97
Accumulated Depreciation, Total - - - -31.36
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 42.43 32.28 30.79 30.21
Other Assets, Total -131.66 -76.73 -30.43 -17.98
Total Current Liabilities 134.66 93.7 101.63 121.86
Accounts Payable 24.85 18.44 32.26 45.35
Payable/Accrued - - - -
Accrued Expenses 58.73 47.03 42.7 49.89
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 13.9 13.85 13.23 12.76
Other Current liabilities, Total 37.19 14.39 13.44 13.86
Total Liabilities 260.5 223.48 166.43 193.11
Total Long Term Debt 88.57 90.35 20.39 23.45
Long Term Debt 88.57 90.35 20.39 23.45
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -37.72 -35.56 44.4 47.8
Total Equity 561.6 490.84 121.92 155.83
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2.44 2.37 2.26 2.26
Additional Paid-In Capital 2267.75 2227.8 1854.74 1847.64
Retained Earnings (Accumulated Deficit) -1708.59 -1739.33 -1735.09 -1694.07
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 822.1 714.33 288.34 348.94
Total Common Shares Outstanding 265.84 263.45 226.07 226.05
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IMGN Comments

Write your thoughts about ImmunoGen Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gale Lazarus
Gale Lazarus May 22, 2023 12:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great stock. Fantastic drug for Ovarian cancer
Reply
2 0
Report
Nhat Doan
Nhat Doan May 16, 2023 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Being Slaughted for Eagles Meat today 🥰👍
Reply
1 0
Report
Nhat Doan
Nhat Doan May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ SELL OFF AND SHORT NOW BEFORE HAILO OPEN 🤗🥰👌👍💰
Reply
2 1
Report
Mindaugas Mindaugas
Mindaugas Mindaugas May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
guessing?
Reply
0 0
Report
AMARØK CS
AMARØK CS May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
should I sell?
Reply
1 0
Report
Gale Lazarus
Gale Lazarus May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy
Reply
0 0
Report
Nhat Doan
Nhat Doan May 03, 2023 5:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ $ 200M Offer to Sell; TOMORROW is Big Sell Off 😞😩👎
Reply
2 1
Report
Gary Schachtschneider
Gary Schachtschneider May 03, 2023 2:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
PRICE TARGET raised to $15 by Truist Securities
Reply
1 0
Report
Nhat Doan
Nhat Doan May 03, 2023 10:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ IT MUST DROP BACK ABOUT $8 WITH IN 2 WEEKS, LONG BUYERS MUST CASH OUT FOR PROFIT & SHORT SELLERS BE PATIENT AND WAIT +💰💰💰💰💰
Reply
1 0
Report
Luka Tsirekidze
Luka Tsirekidze Mar 01, 2023 3:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
its bull time here this week
Reply
1 0
Report
robert revesz
robert revesz Feb 07, 2022 4:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hi, do you have any news / "feelings" how will this stock behave after the earnings report coming up?
Reply
0 1
Report
Joe Jordan
Joe Jordan Nov 30, 2021 10:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug TrialImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response (DOR) of 5.9 months in the 106-person trial.
Reply
3 0
Report
robert revesz
robert revesz Nov 30, 2021 7:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hello, does anyone know what has happened? +40%???
Reply
1 0
Report
Thao Bui
Thao Bui Nov 30, 2021 7:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
take profit and waiting it down and buy more
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email